Nevena Damjanov, MD, Chief of GI Oncology, Abramson Cancer Center at Penn Presbyterian, University of Pennsylvania discusses, The Impact Of The ReDOS study In HCC. At The 2019 Gastrointestinal Cancers Symposium In San Francisco, CA On Jan 17, 2019. http://obroncology.com